A Study of Cizutamig in Patients With Immunoglobulin A Nephropathy
Status:
ENROLLING_BY_INVITATION
Trial end date:
2027-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, PK, PD, immunogenicity, and preliminary clinical activity of cizutamig in patients with IgAN.